T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
JELD-WEN Holding
JELD
$169M
| $22.1M | ﹤0.01% |
1,040,650
+519
| +0% | +$10.5K |
|
1152
Insteel Industries
IIIN
$635M
| $22M | ﹤0.01% |
1,054,718
+138,239
| +15% | +$2.78M |
|
1153
Criteo S.A. Ordinary Shares
CRTO
$892M
| $21.8M | ﹤0.01% |
1,269,408
-441,676
| -26% | -$8.68M |
|
|
AYX
1154
DELISTED
Alteryx Inc
AYX
| $21.8M | ﹤0.01% |
199,656
+83,484
| +72% | +$7.6M |
|
1155
Ponce Financial Group
PDLB
$503M
| $21.8M | ﹤0.01% |
2,126,452
-20,009
| -0.9% | -$204K |
|
|
MRO
1156
DELISTED
Marathon Oil Corporation
MRO
| $21.5M | ﹤0.01% |
1,514,654
-12,803
| -0.8% | -$198K |
|
1157
FMC
FMC
$1.25B
| $21.1M | ﹤0.01% |
253,967
-428,321
| -63% | -$33.6M |
|
1158
Masco
MAS
$14.8B
| $21.1M | ﹤0.01% |
536,836
-5,811
| -1% | -$224K |
|
|
LOGM
1159
DELISTED
LogMein, Inc.
LOGM
| $21M | ﹤0.01% |
285,392
-917
| -0.3% | -$70.9K |
|
1160
TechnipFMC
FTI
$29.8B
| $21M | ﹤0.01% |
1,088,506
+5,645
| +0.5% | +$99K |
|
1161
Robert Half
RHI
$4.27B
| $20.9M | ﹤0.01% |
365,893
+3,600
| +1% | +$215K |
|
1162
Advance Auto Parts
AAP
$3.4B
| $20.8M | ﹤0.01% |
134,793
-248
| -0.2% | -$40.3K |
|
1163
Badger Meter
BMI
$3.8B
| $20.8M | ﹤0.01% |
347,920
+257,073
| +283% | +$14.2M |
|
|
IFFT
1164
DELISTED
International Flavors & Fragrances Inc. 6.00% Tangible Equity Units
IFFT
| $20.7M | ﹤0.01% |
385,677
-5,088
| -1% | -$267K |
|
1165
Palomar
PLMR
$3.35B
| $20.7M | ﹤0.01% |
+862,636
| New | +$19M |
|
1166
Scholar Rock
SRRK
$6.69B
| $20.7M | ﹤0.01% |
1,303,747
+477,174
| +58% | +$8.84M |
|
|
UNVR
1167
DELISTED
Univar Solutions Inc.
UNVR
| $20.7M | ﹤0.01% |
938,101
-109,462
| -10% | -$2.39M |
|
1168
Pinnacle West Capital
PNW
$12.2B
| $20.5M | ﹤0.01% |
218,401
-1,827
| -0.8% | -$174K |
|
1169
John B. Sanfilippo & Son
JBSS
$1B
| $20.5M | ﹤0.01% |
257,438
-1,294
| -0.5% | -$98.3K |
|
1170
Diageo
DEO
$52.8B
| $20.5M | ﹤0.01% |
119,008
+2,993
| +3% | +$503K |
|
1171
Southern First Bancshares
SFST
$612M
| $20.5M | ﹤0.01% |
522,474
-5,749
| -1% | -$208K |
|
1172
DaVita
DVA
$11.5B
| $20.3M | ﹤0.01% |
360,704
-258,132
| -42% | -$13.4M |
|
1173
Barings BDC
BBDC
$979M
| $20M | ﹤0.01% |
2,034,910
-2,217,290
| -52% | -$22.1M |
|
1174
Ambev
ABEV
$43.6B
| $20M | ﹤0.01% |
4,284,300
+35,100
| +0.8% | +$157K |
|
|
HONE
1175
DELISTED
HarborOne Bancorp
HONE
| $19.9M | ﹤0.01% |
1,909,749
+11,887
| +0.6% | +$120K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.